News
Innovent Biologics has reached a strategic cooperation with Takeda Pharmaceutical Company to jointly advance research and development in the field of cancer treatment. The collaboration between Innovent Biologics and Takeda Pharmaceutical includes options for two late-stage therapies and one early-stage research project
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments